| Record ID | marc_columbia/Columbia-extract-20221130-007.mrc:204422474:2965 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-007.mrc:204422474:2965?format=raw |
LEADER: 02965mam a2200361 a 4500
001 3175791
005 20221020002201.0
008 010807s2001 flua b 001 0 eng
015 $aGBA1-W1347
020 $a0849303435
035 $a(OCoLC)52264267
035 $a(OCoLC)ocm52264267
035 $9AUB8144CU
035 $a(NNC)3175791
035 $a3175791
040 $aUKM$cUKM$dOCLCQ$dNNC$dOrLoB-B
082 04 $a615.78$221
100 1 $aKarch, Steven B.$0http://id.loc.gov/authorities/names/n93027146
245 10 $aKarch's pathology of drug abuse /$cSteven B. Karch.
250 $a3rd ed.
260 $aBoca Raton, Fla. :$bCRC ;$aLondon :$bChapman & Hall,$c2001.
300 $axxi, 541 pages :$billustrations ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aPrevious ed.: 1996.
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tCocaine.$g1.1.$tIncidence.$g1.2.$tEpidemiology.$g1.3.$tHistory.$g1.4.$tCultivation and manufacture.$g1.5.$tDrug constants.$g1.6.$tRoutes of ingestion.$g1.7.$tMetabolism of cocaine and its metabolites.$g1.8.$tProblems of test interpretation.$g1.9.$tCocaine tissue disposition.$g1.10.$tCocaine's effects on catecholamine and the heart.$g1.11.$tExternal markers of cocain abuse.$g1.12.$tToxicity by organ system --$gCh. 2.$tNatural stimulants.$g2.1.$tAbsinthe.$g2.2.$tCaffeine.$g2.3.$tEphedrine.$g2.4.$tKhat --$gCh. 3.$tSynthetic stimulants.$g3.1.$tAmphetamine and methamphetamine.$g3.2.$tMethylphenidat (Ritalin).$g3.3.$tPhenylpropanolamine.$g3.4.$tFenfluramine --$gCh. 4.$tHallucinogens.$g4.1.$tIntroduction.$g4.2.$tIncidence.$g4.3.$tPhenylethylamine drivatives.$g4.4.$tSubstituted amphetamines (phenylisopropylamines).$g4.5.$tPhenylalkylamines --$gCh. 5.$tOpiates.$g5.1.$tIncidence.$g5.2.$tEpidemiology.$g5.3.$tClassification of narcotic agents.$g5.4.$tHistory of opiate abuse.
505 80 $g5.5.$tCultivation and manufacture.$g5.6.$tOpiate classification.$g5.7.$tInterpretation of opiate blood and tissue concentrations.$g5.8.$tMedical consequences of opiate abuse --$gCh. 6.$tDisassociative anesthetics.$g6.1.$tPhencyclidine (PCP).$g6.2.$tKetamine.$g6.3.$t[gamma]-Hydroxybutyrate (GHB) --$gCh. 7.$tAnabolic steroids.$g7.1.$tIncidence.$g7.2.$tEpidemiology.$g7.3.$tHistory.$g7.4.$tSteroid abuse.$g7.5.$tPharmacology.$g7.6.$tSteroid-related disorders.$g7.7.$tDetecting steroid abuse --$gCh. 8.$tSolvents.$g8.1.$tIncidence.$g8.2.$tEpidemiology.$g8.3.$tGeneral considerations.$g8.4.$tAbsorption and tissue disposition.$g8.5.$tClinical syndromes.$gApp. 2.$tBlood alcohol concentrations --$gApp. 3.$tVolume of distribution calculations --$gApp. 4.$tNormal heart weights.
650 0 $aDrug abuse.$0http://id.loc.gov/authorities/subjects/sh85039675
650 0 $aDrug abuse$xPathophysiology.
650 0 $aDrugs$xToxicology.$0http://id.loc.gov/authorities/subjects/sh85039757
740 0 $aPathology of drug abuse.
852 00 $bswx$hRM316$i.K37 2001g